MiR-202-3p inhibits the proliferation and metastasis of lung adenocarcinoma cells by targeting RRM2

Xiaowen Cao,Fangsu Xue,Haoyu Chen,Lu Shen,Xiaosa Yuan,Yunchi Yu,Ying Zong,Lou Zhong,Fang Huang
DOI: https://doi.org/10.21037/atm-22-6089
IF: 3.616
2022-12-27
Annals of Translational Medicine
Abstract:Background: Lung adenocarcinoma (LUAD) is the most common type of lung cancer, and its pathogenesis is still unclear. The present study aimed to investigate the role of <i>miR-202-3p</i> and its downstream target gene, ribonucleotide reductase regulatory subunit M2 (<i>RRM2</i>), in the occurrence and development of LUAD and elucidate the correlation between <i>RRM2</i> and the clinicopathological stage and prognosis of LUAD.Methods: The expression of <i>miR-202-3p</i> was analyzed using the CancerMIRNome database and quantitative polymerase chain reaction (qPCR). The effects of <i>miR-202-3p</i> and <i>RRM2</i> on the proliferation, migration, and invasion of A549 cells were analyzed. A dual luciferase reporter assay was used to verify the targeting of <i>miR-202-3p</i> and <i>RRM2</i>. Additionally, the correlation between <i>RRM2</i> expression and clinicopathology was analyzed.Results: (I) <i>MiR-202-3p</i> was lowly expressed in LUAD and the LUAD cell lines. qPCR confirmed that microRNA (miRNA) transfection was effective and sufficient for subsequent experiments. (II) <i>MiR-202-3p</i> inhibited the proliferation, invasion, and migration of LUAD cells. (III) There was a targeting relationship between <i>miR-202-3p</i> and <i>RRM2</i>, and <i>miR-202-3p</i> affected the expression of the <i>RRM2</i> protein. <i>RRM2</i> was highly expressed in lung cancer tissue. (IV) <i>RRM2</i> was associated with the clinicopathological staging of lung cancer. The prognosis of patients with low <i>RRM2</i> expression was better, and the prognostic sensitivity of <i>RRM2</i> to lung cancer was high. <i>RRM2</i> may exert its effects via the Notch pathway. (V) Si-<i>RRM2</i> inhibited the expression of the <i>RRM2</i> protein. <i>RRM2</i> promoted the proliferation, migration, and invasion of LUAD cells. A <i>miR-202-3p</i> inhibitor restored the inhibitory effect of si-<i>RRM2</i> on LUAD cells.Conclusions: <i>MiR-202-3p</i> was lowly expressed in lung cancer tissue. <i>MiR-202-3p</i> overexpression inhibited the proliferation and metastasis of lung cancer cells. <i>RRM2</i> was highly expressed in lung cancer tissue and promoted the proliferation and metastasis of lung cancer cells. <i>MiR-202-3p</i> targeted and inhibited <i>RRM2</i>, thereby reducing the proliferation and metastasis of LUAD cells. LUAD patients with low <i>RRM2</i> expression had a better prognosis, and the expression level of <i>RRM2</i> was correlated with the clinical characteristics of lung cancer patients.
oncology,medicine, research & experimental
What problem does this paper attempt to address?